Metagenomi, Inc.
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| – | +191.9% | -12.0% | -11.0% | -31.9% | |
| – | +236.9% | -24.2% | -7.3% | -35.8% | |
| – | +369.4% | -23.8% | -80.5% | +52.3% | |
| – | +234.8% | -25.1% | -8.4% | -35.2% | |
| – | +160.0% | +92.4% | -48.7% | -75.7% | |
| – | +180.1% | +2.4% | -82.1% | -30.3% | |
| – | +92.8% | +41.9% | -45.8% | -38.5% | |
| – | +120.5% | +126.2% | +63.2% | +7.7% | |
| – | +48.5% | -10.9% | -70.2% | +179.4% | |
| – | – | – | – | – | |
| – | – | – | – | -32.5% | |
| – | – | – | – | – | |
| – | +531.9% | +0.0% | -0.1% | -0.4% |
Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.